Many investors, including Vanguard Group, Capital International, and Ameriprise Financial, have increased their shares in Abbott Laboratories recently. Vanguard Group now owns over 165 million shares worth about $18.8 billion. Capital International has raised its holdings to 70 million shares, worth approximately $8 billion. Overall, institutional investors own 75.18% of Abbott’s stock.
Insider Transactions at Abbott Laboratories
CEO Robert B. Ford sold 141,679 shares on September 12 for about $16.5 million, reducing his total holdings to 220,059 shares worth around $25.6 million. He disclosed this transaction to the SEC. Corporate insiders hold 1.10% of the company.
Analyst Ratings Changes
Recent analyst reports show mixed ratings for Abbott Laboratories (ABT). Citigroup raised its target price from $119 to $127 and maintained a “buy” rating. Piper Sandler set a target of $131 with an “overweight” rating. Jefferies reaffirmed a “hold” rating with a $120 target. Overall, Abbott has an average rating of “Moderate Buy” and a target price of $124.33.
Check Out Our Latest Stock Analysis on Abbott Laboratories
Abbott Laboratories Price Performance
Abbott’s stock opened at $112.23, with a market cap of $195.24 billion. The company has a P/E ratio of 34.96, a P/E/G ratio of 2.86, and a beta of 0.72. Its 50-day moving average is $112.22, and the 200-day is $108.22. The stock’s one-year low is $89.67, and high is $121.64.
Abbott Laboratories Dividend Announcement
Abbott has declared a quarterly dividend of $0.55, payable on November 15 to shareholders recorded by October 15. This equates to an annual dividend of $2.20, yielding 1.96%.
Abbott Laboratories Company Profile
Abbott Laboratories develops and sells healthcare products globally, operating in four areas: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. They offer various pharmaceuticals for various health conditions.
Featured Stories
- Five stocks we like better than Abbott Laboratories
- How to Effectively Use the MarketBeat Ratings Screener
- Beat the Volatility: Top 3 Low-Beta Stocks to Watch
- Find and Profitably Trade Stocks at 52-Week Lows
- Visa and Mastercard: Top Payment Stocks to Watch After Rate Cuts
- What is an SEC Filing?
- When Is the Best Time to Invest in Mutual Funds?
Want to see what other hedge funds are holding ABT? Visit HoldingsChannel.com for the latest filings and insider trades for Abbott Laboratories (NYSE:ABT).
Receive News & Ratings for Abbott Laboratories Daily – Enter your email below to get a daily summary of news and ratings for Abbott Laboratories and related companies with MarketBeat.com’s FREE daily email newsletter.
`
